Cargando…

PM420. Additional clinical effects of long-term clozapine therapy for chronic schizophrenia

Detalles Bibliográficos
Autores principales:	Seo, Young Eun, Bae, Sangbin, Park, Jong-Ik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616355/ http://dx.doi.org/10.1093/ijnp/pyw041.420

Ejemplares similares

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

PM381. Reason for clozapine discontinuation
por: Cho, Jin-Woo, et al.
Publicado: (2016)

PM415. Clozapine-induced anemia and thrombocytosis
por: Park, Hanson, et al.
Publicado: (2016)

S41. SHORT- AND LONG-TERM OUTCOMES OF VITAMIN D SUPPLEMENTATION IN CLOZAPINE TREATED CHRONIC SCHIZOPHRENIA PATIENTS
por: Krivoy, Amir, et al.
Publicado: (2018)

PM392. Clozapine-induced anemia and thrombocytosis
por: Jeon, Soyeon
Publicado: (2016)

PM512. The effectiveness of clozapine in reducing medical costs associated with treatment-resistant schizophrenia in Japanese patients
por: Kikuchi, Yuka
Publicado: (2016)

PM412. Emergence of Tardive Dyskinesia upon Clozapine Treatment: A Case Report
por: Moon, Sun-Young, et al.
Publicado: (2016)

PM493. Interactions of tardive dyskinesia with cognitive function in patients with schizophrenia: worsening of working memory with clozapine treatment
por: Kim, Soo In, et al.
Publicado: (2016)

PM422. Creatine Phospho Kinase Elevations with Clozapine
por: Takahashi, Yuka
Publicado: (2016)

PM428. Combination of Clozapine with Long Acting Injectable Antipsychotics in Treatment Resistant Schizophrenia: Preliminary Evidence from Health Care Utilization Indices
por: Grimminck, Rachel, et al.
Publicado: (2016)

F3. A CASE OF LEUKOCYTOSIS ASSOCIATED WITH CLOZAPINE TREATMENT FOR THE MANAGEMENT OF CHRONIC SCHIZOPHRENIA
por: Song, Min-Kyu, et al.
Publicado: (2018)

PM389. Preliminary Genetic Model Predicting Clozapine Response
por: Huang, Eric, et al.
Publicado: (2016)

PM527. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics
por: Melkersson, Kristina, et al.
Publicado: (2016)

O5.1. CLOZAPINE AND LONG-TERM MORTALITY RISK IN PATIENTS WITH SCHIZOPHRENIA: PRELIMINARY RESULTS FROM A META-ANALYSIS
por: Vermeulen, Jentien, et al.
Publicado: (2018)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

Long-term treatment with clozapine and verbal memory performance in schizophrenia
por: Czepielewski, Letícia S., et al.
Publicado: (2018)

PM358. Antidepressant Prescription pattern and Clinical Correlates for Schizophrenia
por: Kim, Jungwon, et al.
Publicado: (2016)

Electroconvulsive therapy combined with clozapine in the management of ultra-resistant schizophrenia
por: Khouadja, S., et al.
Publicado: (2021)

PM442. Short-Term Response of Serum Brain-Derived Neurotrophic Factor to Repetitive Transcranial Magnetic Stimulation in Patients with Chronic Schizophrenia
por: Hwang, Tae-Young
Publicado: (2016)

PM413. Metabolic Syndrome in Patients With Schizophrenia Receiving Long-Term Treatment With Lurasidone, Quetiapine XR, or Risperidone
por: Newcomer, John W., et al.
Publicado: (2016)

PM461. Inflammation in schizophrenia: Imaging genetics
por: Hwang, Wu Jeong, et al.
Publicado: (2016)

PM406. Urinary retention as a rare adverse effect of clozapine: a case report
por: Lin, Yi-Ting
Publicado: (2016)

Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

PM471. Distinguishing Changes in Schizophrenia RSNs Using Regional Correlation for Node Identification
por: Sohn, William, et al.
Publicado: (2016)

S234. ONE-YEAR OUTCOME AND USE OF CLOZAPINE IN FIRST-EPISODE SCHIZOPHRENIA
por: Drosos, Petros, et al.
Publicado: (2018)

Electroconvulsive therapy in a patient with resistant paranoid schizophrenia treated with clozapine
por: Castelao-Almodóvar, S., et al.
Publicado: (2021)

The usage of clozapine in a patient with schizophrenia and epilepsy: A case report
por: Karnickas, M., et al.
Publicado: (2021)

Resistant schizophrenia in a patient with oculocutaneous albinism successfully treated with clozapine
por: Jelti, A., et al.
Publicado: (2022)

Lurasidone augmentation to clozapine in treatment resistant schizophrenia: A pilot study
por: Arienti, V., et al.
Publicado: (2023)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?
por: Darriba, H. Becerra
Publicado: (2021)

Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome
por: Kammoun, I., et al.
Publicado: (2022)

420. Prevalence of Oropharyngeal Meningococcal Carriage in an Urban STD Clinic
por: Turner, Abigail N, et al.
Publicado: (2019)

PM441. Long term atypical antipsychotic treatment improves cognitive performance in schizophrenia but not surpassing conventional antipsychotic drugs effects.
por: Vera, Gabriel Selva, et al.
Publicado: (2016)

PM453. Association between CSF1R gene polymorphism and the risk of schizophrenia in Korean population
por: Kang, Won Sub, et al.
Publicado: (2016)

T224. THE FUNCTIONAL CONNECTIVITY DERIVED WITH BIVARIATE ANALYSIS, COHERENCE AND PHASE LOCKING VALUE IN PATIENTS WITH SCHIZOPHRENIA UNDER CLOZAPINE
por: Kim, Yong Sik, et al.
Publicado: (2018)

PM394. The outcome of paliperidone palmitate in schizophrenia
por: Ju, Po-Chung
Publicado: (2016)

PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies
por: Correll, Christoph U., et al.
Publicado: (2016)

T81. LONG-TERM COURSE OF COGNITIVE PERFORMANCE IN PATIENTS WITH CHRONIC SCHIZOPHRENIA
por: Martins, Thaís, et al.
Publicado: (2018)

PM510. Temporal relationship of mismatch negativity multiple generators in patients with schizophrenia and subjects at clinical high risk for psychosis
por: Kim, Minah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1i37b00jdiobckjulcrqup0lir